Genome-wide expression profiling of human lymphoblastoid cell lines implicates integrin beta-3 in the mode of action of antidepressants

Translational Psychiatry

Volumn 3, Issue , 2013, Pages

  Oved, K ^a   Morag, A ^a   Pasmanik Chor, M ^a   Rehavi, M ^a   Shomron, N ^a   Gurwitz, D ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

CD61; GPIIIa; Human lymphoblastoid cell lines; ITGB3; MicroRNAs; Serotonin transporter; SSRI antidepressants

Indexed keywords

BETA3 INTEGRIN; BINDING PROTEIN; CHL1 PROTEIN; MICRORNA 221; MICRORNA 222; PAROXETINE; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; CHL1 PROTEIN, HUMAN; ITGB3 PROTEIN, HUMAN; MESSENGER RNA; MICRORNA; MIRN221 MICRORNA, HUMAN; MIRN222 MICRORNA, HUMAN; SLC6A4 PROTEIN, HUMAN;

ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; MICROARRAY ANALYSIS; NERVE CELL DIFFERENTIATION; PHARMACOGENOMICS; PROTEIN EXPRESSION; SYNAPTOGENESIS; CELL LINE; DRUG EFFECT; GENETICS; LYMPHOCYTE; METABOLISM; NERVOUS SYSTEM DEVELOPMENT; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

CELL ADHESION MOLECULES; CELL LINE; GENE EXPRESSION PROFILING; HUMANS; INTEGRIN BETA3; LYMPHOCYTES; MICRORNAS; NEUROGENESIS; PAROXETINE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE ANALYSIS, RNA; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS;

EID: 84886652538     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2013.86     Document Type: Article

References (51)

1. Gelenberg AJ. A review of the current guidelines for depression treatment. J Clin Psychiatry 2010; 71: e15.
2. Rayner L, Price A, Evans A, Valsraj K, Hotopf M, Higginson IJ. Antidepressants for the treatment of depression in palliative care: systematic review and meta-analysis. Palliat Med 2011; 25: 36-51.
3. Cipriani A, Purgato M, Furukawa TA, Trespidi C, Imperadore G, Signoretti A et al. Citalopram versus other anti-depressive agents for depression. Cochrane Database Syst Rev 2012; 7: CD006534.
4. van Praag HM, Kahn R, Asnis GM, Lemus CZ, Brown SL. Therapeutic indications for serotonin-potentiating compounds: a hypothesis. Biol Psychiatry 1987; 22: 205-212.
5. Price LH, Charney DS, Delgado PL, Heninger GR. Lithium and serotonin function: implications for the serotonin hypothesis of depression. Psychopharmacology (Berl) 1990; 100: 3-12.
6. Hanson ND, Owens MJ, Nemeroff CB. Depression, antidepressants, and neurogenesis: a critical reappraisal. Neuropsychopharmacology 2011; 36: 2589-60.
7. Eisch AJ, Petrik D. Depression and hippocampal neurogenesis: a road to remission? Science 2012; 338: 72-75.
8. Bambico FR, Belzung C.. Novel insights into depression and antidepressants: a synergy between synaptogenesis and neurogenesis? Curr Top Behav Neurosci 2012; 15: 243-291.
9. Mateus-Pinheiro A, Pinto L, Bessa JM, Morais M, Alves ND, Monteiro S, Patrício P, Almeida OF, Sousa N. Sustained remission from depressive-like behavior depends on hippocampal neurogenesis. Transl Psychiatry 2013; 3: e210.
10. Thomas RM, Peterson DA. Even neural stem cells get the blues: evidence for a molecular link between modulation of adult neurogenesis and depression. Gene Expr 2008; 14: 183-193.
11. Eyre H, Baune BT. Neuroplastic changes in depression: a role for the immune system. Psychoneuroendocrinology 2012; 37: 1397-1416.
12. Danzer SC. Depression, stress, epilepsy and adult neurogenesis. Exp Neurol. 2012; 233: 22-32.
13. Benmansour S, Cecchi M, Morilak DA, Gerhardt GA, Javors MA, Gould GG, Frazer A. Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level. J Neurosci 1999; 19: 10494-10501.
14. Benmansour S, Owens WA, Cecchi M, Morilak DA, Frazer A. Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter. J Neurosci 2002; 22: 6766-6772.
15. Mirza NR, Nielsen EO, Troelsen KB. Serotonin transporter density and anxiolyticlike effects of antidepressants in mice. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 858-866.
16. Meyer JH. Imaging the serotonin transporter during major depressive disorder and antidepressant treatment. J Psychiatry Neurosci 2007; 32: 86-102.
17. Huang Y, Zheng MQ, Gerdes JM. Development of effective PET and SPECT imaging agents for the serotonin transporter: has a twenty-year journey reached its destination? Curr Top Med Chem 2010; 10: 1499-1526.
18. Descarries L, Riad M. Effects of the antidepressant fluoxetine on the subcellular localization of 5-HT1A receptors and SERT. Philos Trans R Soc Lond B Biol Sci 2012; 367: 2416-2425.
19. Overstreet DH. Modeling depression in animal models. Methods Mol Biol 2012; 829: 125-144.
20. Harro J. Animal models of depression vulnerability. Curr Top Behav Neurosci 2013; 14: 29-54.
21. Sie L, Loong S, Tan EK.. Utility of lymphoblastoid cell lines. J Neurosci Res 2009; 87: 1953-1959.
22. Shim SM, Nam HY, Lee JE, Kim JW, Han BG, Jeon JP. MicroRNAs in human lymphoblastoid cell lines. Crit Rev Eukaryot Gene Expr 2012; 22: 189-196.
23. Wheeler HE, Dolan ME. Lymphoblastoid cell lines in pharmacogenomic discovery and clinical translation. Pharmacogenomics 2012; 13: 55-70.
24. Morag A, Pasmanik-Chor M, Oron-Karni V, Rehavi M, Stingl JC, Gurwitz D. Genome-wide expression profiling of human lymphoblastoid cell lines identifies CHL1 as a putative SSRI antidepressant response biomarker. Pharmacogenomics 2011; 12: 171-184.
25. Oved K, Morag A, Pasmanik-Chor M, Oron-Karni V, Shomron N, Rehavi M, Stingl JC, Gurwitz D. Genome-wide miRNA expression profiling of human lymphoblastoid cell lines identifies tentative SSRI antidepressant response biomarkers. Pharmacogenomics 2012; 13: 1129-1139.
26. Ango F, Wu C, Van der Want JJ, Wu P, Schachner M, Huang ZJ. Bergmann glia and the recognition molecule CHL1 organize GABAergic axons and direct innervation of Purkinje cell dendrites. PLoS Biol 2008; 6: e103.
27. Ye H, Tan YL, Ponniah S, Takeda Y, Wang SQ, Schachner M et al. Neural recognition molecules CHL1 and NB-3 regulate apical dendrite orientation in the neocortex via PTP alpha. EMBO J 2008; 27: 188-200.
28. Tian N, Leshchyns'ka I, Welch JH, Diakowski W, Yang H, Schachner M, Sytnyk V. Lipid raft-dependent endocytosis of close homolog of adhesion molecule L1 (CHL1) promotes neuritogenesis. J Biol Chem 2012; 287: 44447-44463.
29. Demyanenko GP, Siesser PF, Wright AG, Brennaman LH, Bartsch U, Schachner M, Maness PF. L1 and CHL1 cooperate in thalamocortical axon targeting. Cereb Cortex 2011; 21: 401-412.
30. Clark SL, Adkins DE, Aberg K, Hettema JM, McClay JL, Souza RP, van den Oord EJ. Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D. Psychol Med 2012; 42: 1151-1162.
31. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003; 4: 249-264.
32. Cingolani LA, Goda Y.. Differential involvement of beta3 integrin in pre- and postsynaptic forms of adaptation to chronic activity deprivation. Neuron Glia Biol 2008; 4: 179-187.
33. Pozo K, Cingolani LA, Bassani S, Laurent F, Passafaro M, Goda Y. β3 integrin interacts directly with GluA2 AMPA receptor subunit and regulates AMPA receptor expression in hippocampal neurons. Proc Natl Acad Sci USA 2012; 109: 1323-1328.
34. Aston C, Jiang L, Sokolov BP. Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol Psychiatry 2005; 10: 309-322.
35. Xu D, Sharma C, Hemler ME. Tetraspanin12 regulates ADAM10-dependent cleavage of amyloid precursor protein. FASEB J 2009; 23: 3674-3681.
36. Okamoto N, Hatsukawa Y, Shimojima K, Yamamoto T. Submicroscopic deletion in 7q31 encompassing CADPS2 and TSPAN12 in a child with autism spectrum disorder and PHPV. Am J Med Genet A 2011; 155A: 1568-1573.
37. Kishi N, Tang Z, Maeda Y, Hirai A, Mo R, Ito M et al. Murine homologs of deltex define a novel gene family involved in vertebrate Notch signaling and neurogenesis. Int J Dev Neurosci 2001; 19: 21-35.
38. Fujita K, Yasui S, Shinohara T, Ito K. Interaction between NF-kB signaling and Notch signaling in gliogenesis of mouse mesencephalic neural crest cells. Mech Dev 2011; 128: 496-509.
39. Read ML, Mir S, Spice R, Seabright RJ, Suggate EL, Ahmed Z et al. Profiling RNA interference (RNAi)-mediated toxicity in neural cultures for effective short interfering RNA design. J Gene Med 2009; 11: 523-534.
40. Zhou R, Yuan P, Wang Y, Hunsberger JG, Elkahloun A, Wei Y et al. Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers. Neuropsychopharmacology 2009; 34: 1395-1405.
41. Horike S, Cai S, Miyano M, Cheng JF, Kohwi-Shigematsu T. Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat Genet 2005; 37: 31-40.
42. Zhang Z, Liu J, Kaur M, Krantz ID. Characterization of DNA methylation and its association with other biological systems in lymphoblastoid cell lines. Genomics 2012; 99: 209-219.
43. Yasui-Furukori N, Nakagami T, Kaneda A, Inoue Y, Suzuki A, Otani K, Kaneko S. Inverse correlation between clinical response to paroxetine and plasma drug concentration in patients with major depressive disorders. Hum Psychopharmacol 2011; 26: 602-608.
44. Vincent M, Oved K, Morag A, Pasmanik-Chor M, Oron-Karni V, Shomron N, Gurwitz D. Genome-wide transcriptomic variations of human lymphoblastoid cell lines: insights from pairwise gene-expression correlations. Pharmacogenomics 2012; 13: 1893-1904.
45. Carneiro AM, Cook EH, Murphy DL, Blakely RD. Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans. J Clin Invest 2008; 118: 1544-1552.
46. Carter MD, Shah CR, Muller CL, Crawley JN, Carneiro AM, Veenstra-VanderWeele J. Absence of preference for social novelty and increased grooming in integrin b3 knockout mice: initial studies and future directions. Autism Res 2011; 4: 57-67.
47. Ellegood J, Henkelman RM, Lerch JP. Neuroanatomical assessment of the integrin b3 mouse model related to autism and the serotonin system using high resolution MRI. Front Psychiatry 2012; 3: 37.
48. Buhusi M, Midkiff BR, Gates AM, Richter M, Schachner M, Maness PF. Close homolog of L1 is an enhancer of integrin-mediated cell migration. J Biol Chem 2003; 278: 25024-25031.
49. Demyanenko GP, Schachner M, Anton E, Schmid R, Feng G, Sanes J, Maness PF. Close homolog of L1 modulates area-specific neuronal positioning and dendrite orientation in the cerebral cortex. Neuron 2004; 44: 423-437.
50. Schlatter MC, Buhusi M, Wright AG, Maness PF. CHL1 promotes Sema3A-induced growth cone collapse and neurite elaboration through a motif required for recruitment of ERM proteins to the plasma membrane. J Neurochem 2008; 104: 731-744.
51. Whyte A, Jessen T, Varney S, Carneiro AM. Serotonin transporter and integrin beta 3 genes interact to modulate serotonin uptake in mouse brain. Neurochem Int. advance online publication, 28 September 2013; doi:pii:S0197-0186(13)00241-6.10.1016/j.neuint.2013.09.014 (e-pub ahead of print).